Long-term exposure to ambient air pollutant and acute exacerbations of chronic obstructive pulmonary disease: a retrospective cohort study in Xinjiang, China
Frontiers in Public Health · 2025
DOI: 10.3389/fpubh.2025.1658252 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Frontiers in Public Health, 2025. Verfasst von Zhichuang Lian und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, People's Hospital of Xinjiang Uygur Autonomous Region, Xinjiang, China. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Air Pollutants, Environmental Exposure, Air Pollution. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: COPD
Abstract (Originalsprache)
Introduction
While short-term ambient air pollution is implicated in chronic obstructive pulmonary disease (COPD) exacerbations, evidence for chronic exposure remains limited, particularly in vulnerable subgroups. This study evaluates longitudinal associations between major air pollutants and acute exacerbations (AEs), while identifying high-risk demographic and clinical subgroups.
Methods
We analyzed 660 COPD patients from People’s Hospital of Xinjiang (2020–2023). Annual average concentrations of PM 2.5 , PM 10 , O 3 , NO 2 , SO 2 , and CO were geocoded to residential addresses. Single-pollutant logistic regression models adjusted for 12 clinical/sociodemographic confounders assessed AE risks, with robustness verified by two-pollutant sensitivity analyzes. Stratified analyzes examined effect modification across 10 key parameters including disease severity, smoking status, comorbidities, and sociodemographic characteristics.
Results
Long-term ozone exposure demonstrated significant AE risk elevation (OR = 1.007, p = 0.046). This association was confirmed to be robust in two-pollutant models. Stratified analyzes revealed amplified effects in males (OR = 1.009, p = 0.046), those aged over 65 years (OR = 1.012, p = 0.014), Han ethnicity (OR = 1.019, p = 0.003), those with prior-year AEs (OR = 1.008, p = 0.048), and non-asthmatics (OR = 1.014, p = 0.009).
Conclusion
This study establishes chronic ozone exposure as an emerging environmental determinant of COPD exacerbations, with disproportionate impacts on vulnerable subgroups. Our findings demand urgent integration of ozone mitigation into national respiratory health strategies and precision public health approaches to address environmental health inequities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, People's Hospital of Xinjiang Uygur Autonomous Region, Xinjiang, China.
- Yidu Cloud Technology Inc., Beijing, China.
- Department of Health Information Management, People's Hospital of Xinjiang Uygur Autonomous Region, Xinjiang, China.
- Department of Automation, Tsinghua University, Beijing, China.
Zitieren
APA
Lian, Z., Cui, M., Liu, C., Chen, Y., Zhang, L., Wang, B., Yakufu, N., Xu, J., Li, L., Wei, X., & Kelimu, J. (2025). Long-term exposure to ambient air pollutant and acute exacerbations of chronic obstructive pulmonary disease: a retrospective cohort study in Xinjiang, China. Frontiers in Public Health. https://doi.org/10.3389/fpubh.2025.1658252
Vancouver
Lian Z, Cui M, Liu C, Chen Y, Zhang L, Wang B, et al. Long-term exposure to ambient air pollutant and acute exacerbations of chronic obstructive pulmonary disease: a retrospective cohort study in Xinjiang, China. Frontiers in Public Health. 2025. doi:10.3389/fpubh.2025.1658252
BibTeX
@article{Lian2025,
author = {Lian, Zhichuang and Cui, Mengxuan and Liu, Chao and Chen, Ying and Zhang, Ling and Wang, Bei and Yakufu, Nurula and Xu, Jiming and Li, Linfeng and Wei, Xuemei and Kelimu, Julaiti},
title = {Long-term exposure to ambient air pollutant and acute exacerbations of chronic obstructive pulmonary disease: a retrospective cohort study in Xinjiang, China},
journal = {Frontiers in Public Health},
year = {2025},
doi = {10.3389/fpubh.2025.1658252}
}
EUVIMED